Literature DB >> 31449874

Different effects of high-protein/low-carbohydrate versus standard hypocaloric diet on insulin resistance and lipid profile: Role of rs16147 variant of neuropeptide Y.

Daniel Antonio de Luis1, Olatz Izaola2, David Primo2, Rocio Aller2.   

Abstract

BACKGROUND AND AIMS: Few studies have assessed the effect of the NPY gene rs16147 variant on metabolic response following a dietary intervention. We evaluated the effect of rs16147 on body weight and biochemical changes after a high-protein/low-carbohydrate hypocaloric diet compared with a standard severe hypocaloric diet over 9 months.
MATERIALS AND METHODS: A population of 270 obese individuals was enrolled. At baseline, participants were randomly allocated to one of two hypocaloric diets, high protein (Diet HP) or standard (Diet S), for a period of 9 months.
RESULTS: After both diets, all genotypes showed decreased body mass index, weight, fat mass, waist circumference, and leptin levels. Participants with the minor allele (A) assigned to the HP diet showed decreases in total cholesterol (-6.5 ± 4.8 vs 10.1 ± 4.1 mg/dL; p < 0.05), LDL cholesterol (-5.9 ± 3.8 vs 9.6 ± 2.4 mg/dL; p < 0.05), triglycerides (-1.0 ± 4.8 vs 16.2 ± 4.1 mg/dL; p < 0.05), insulin (-0.5 ± 2.8 vs 1.7 ± 2.1 UI/L; p < 0.05), HOMA-IR (-0.2 ± 2.1 vs 0.5 ± 2.0 units; p < 0.05), and CRP (-0.3 ± 0.4 vs 1.3 ± 0.2 mg/dL; p < 0.05). Participants with the minor allele assigned to diet S also showed decreases in total cholesterol (-6.1 ± 4.1 vs 14.4 ± 3.1 mg/dL; p < 0.05), LDL-cholesterol (-3.1 ± 2.8 vs 15.0 ± 3.1 mg/dL; p < 0.05), triglycerides (-6.9 ± 4.1 vs 13.2 ± 4.0 mg/dL; p < 0.05), insulin (-0.3 ± 2.1 vs. -1.2 ± 0.2 UI/L: p < 0.05), HOMA-IR (-0.3 ± 2.1 vs. -1.6 ± 1.1 units: p < 0.05), and CRP (-0.4 ± 0.1 vs 1.1 ± 0.2 mg/dL; p < 0.05).
CONCLUSION: In obese Caucasians, the presence of the A allele of the rs16147 genetic variant produces a better metabolic response that is secondary to weight loss with two different hypocaloric diets.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hypocaloric diet; NPY gene; Rs16147; SNP

Year:  2019        PMID: 31449874     DOI: 10.1016/j.diabres.2019.107825

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  4 in total

Review 1.  Low-carbohydrate versus balanced-carbohydrate diets for reducing weight and cardiovascular risk.

Authors:  Celeste E Naude; Amanda Brand; Anel Schoonees; Kim A Nguyen; Marty Chaplin; Jimmy Volmink
Journal:  Cochrane Database Syst Rev       Date:  2022-01-28

Review 2.  Effect of carbohydrate-restricted diets and intermittent fasting on obesity, type 2 diabetes mellitus, and hypertension management: consensus statement of the Korean Society for the Study of obesity, Korean Diabetes Association, and Korean Society of Hypertension.

Authors:  Jong Han Choi; Yoon Jeong Cho; Hyun-Jin Kim; Seung-Hyun Ko; Suk Chon; Jee-Hyun Kang; Kyoung-Kon Kim; Eun Mi Kim; Hyun Jung Kim; Kee-Ho Song; Ga Eun Nam; Kwang Il Kim
Journal:  Clin Hypertens       Date:  2022-06-01

Review 3.  Effect of Carbohydrate-Restricted Diets and Intermittent Fasting on Obesity, Type 2 Diabetes Mellitus, and Hypertension Management: Consensus Statement of the Korean Society for the Study of Obesity, Korean Diabetes Association, and Korean Society of Hypertension.

Authors:  Jong Han Choi; Yoon Jeong Cho; Hyun-Jin Kim; Seung-Hyun Ko; Suk Chon; Jee-Hyun Kang; Kyoung-Kon Kim; Eun Mi Kim; Hyun Jung Kim; Kee-Ho Song; Ga Eun Nam; Kwang Il Kim
Journal:  Diabetes Metab J       Date:  2022-05-25       Impact factor: 5.893

Review 4.  Effect of Carbohydrate-Restricted Diets and Intermittent Fasting on Obesity, Type 2 Diabetes Mellitus, and Hypertension Management: Consensus Statement of the Korean Society for the Study of Obesity, Korean Diabetes Association, and Korean Society of Hypertension.

Authors:  Jong Han Choi; Yoon Jeong Cho; Hyun-Jin Kim; Seung-Hyun Ko; Suk Chon; Jee-Hyun Kang; Kyoung-Kon Kim; Eun Mi Kim; Hyun Jung Kim; Kee-Ho Song; Ga Eun Nam; Kwang Il Kim
Journal:  J Obes Metab Syndr       Date:  2022-06-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.